

Cancer Prevention Research 2, 773, September 1, 2009. Published Online First September 8, 2009;
doi: 10.1158/1940-6207.CAPR-09-0156
© 2009 American Association for Cancer Research
The Monkey, the Hen, and the Mouse: Models to Advance Ovarian Cancer Chemoprevention
Karen H. Lu,
Melinda S. Yates and
Samuel C. Mok
Authors' Affiliation: Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
Requests for reprints: Karen H. Lu, Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, 1155 Pressler Street, Houston, TX 77230-1439. Phone: 713-745-8902; Fax: 713-792-7586; E-mail: khlu{at}mdanderson.org.
This perspective on Romero et al. (beginning on p. 792 in this issue of the journal) discusses the available animal models of ovarian cancer, including the laying hen, non-human primate, and transgenic rodent models, and their relevance to ovarian cancer chemoprevention studies.
Key Article
-
Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered Mice
- Iris L. Romero, Ilyssa O. Gordon, Sujatha Jagadeeswaran, Keeley L. Mui, Woo Seok Lee, Daniela M. Dinulescu, Thomas N. Krausz, Helen H. Kim, Melissa L. Gilliam, and Ernst Lengyel
Cancer Prevention Research 2009 2: 792-799.
[Abstract]
[Full Text]
[PDF]
Copyright © 2009 by the American Association for Cancer Research.